BioCentury
ARTICLE | Company News

CoGenesys, Teva deal

January 28, 2008 8:00 AM UTC

Teva will acquire CoGenesys for $400 million in cash. Teva said CoGenesys' technology platforms, including its albumin-fusion technology to develop long-acting biopharmaceuticals, will bolster its pos...